Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Single-center Clinical Study to Evaluate the Efficacy and Safetyof Naltrexone Implant in Antagonizing Opioid Agonist Hydromorphone

NCT07014644 is registered in ClinicalTrials.gov with Shenzhen Sciencare Medical Industries Co., Ltd. as lead sponsor.

NCT NCT07014644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07014644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Single-center Clinical Study to Evaluate the Efficacy and Safetyof Naltrexone Implant in Antagonizing Opioid Agonist Hydromorphone
Lead sponsor
Shenzhen Sciencare Medical Industries Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
August 7, 2018
Completion date
May 19, 2020
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid dependence